Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 2/2013

01.02.2013 | Article

Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports

verfasst von: C. Aumeran, P. Guyot, M. Boisnoir, C. Robin-Hennequin, M. Vidal, C. Forestier, O. Traore, O. Lesens, Clermont-Ferrand Biofilm Study Group

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Vancomycin lock solution (LS) is recommended for the conservative treatment of subcutaneous injection port (SIP)-related infections, but may be associated with failure. We used an in vitro dynamic model of biofilm formation in an SIP, based on a continuous flow circulating via a real SIP, to assess the effectiveness of vancomycin (5 mg/ml), daptomycin (5 mg/ml) and ethanol 40 % LS in eradicating a pre-established Staphylococcus epidermidis biofilm. Heparin, Ringer’s lactate and enoxaparin sodium LS were used as controls. The logarithmic reductions of colony-forming units (CFU) were compared by Student’s t-test. After 24 h of exposure, the vancomycin LS did not exert a greater bactericidal effect than the heparin LS control (mean logarithmic reduction: 2.27 ± 0.58 vs. 1.34 ± 0.22, respectively, p = 0.3). The mean logarithmic reduction was greater with daptomycin LS (5.45 ± 0.14 vs. 0.39 ± 0.12, p < 0.01) and ethanol LS (6.79 ± 1.03 vs. 1.43 ± 0.54, p = 0.02). Bacterial revival after exposure to 24 h of LS was assessed. The mean viable bacteria count was significantly higher for vancomycin LS (9.36 ± 0.10 log10CFU) and daptomycin LS (9.16 ± 0.02 log10CFU) than for ethanol LS (2.95 ± 1.65 log10CFU). Ethanol appeared to be the most attractive option to treat SIP-related infection, but its poor ability to entirely disrupt the biofilm structure may require its use in association with a dispersal agent to avoid renewal of the biofilm.
Literatur
1.
Zurück zum Zitat Walser EM (2012) Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol 35:751–764PubMedCrossRef Walser EM (2012) Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol 35:751–764PubMedCrossRef
2.
Zurück zum Zitat Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171PubMedCrossRef Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171PubMedCrossRef
3.
Zurück zum Zitat Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P, Piroth L (2009) Incidence, prévalence et facteurs de risque de survenue d’une première complication infectieuse sur chambres à cathéter implantables. Méd Mal Infect 39:252–258PubMedCrossRef Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P, Piroth L (2009) Incidence, prévalence et facteurs de risque de survenue d’une première complication infectieuse sur chambres à cathéter implantables. Méd Mal Infect 39:252–258PubMedCrossRef
4.
Zurück zum Zitat Opilla M (2008) Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 36:S173.e5–S173.e8CrossRef Opilla M (2008) Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 36:S173.e5–S173.e8CrossRef
5.
Zurück zum Zitat Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel PG, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer MH (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70PubMedCrossRef Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel PG, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer MH (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70PubMedCrossRef
6.
Zurück zum Zitat Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, Fisher S, Levy I (2006) Catheter-associated bloodstream infections in pediatric hematology–oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 28:23–28PubMed Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, Fisher S, Levy I (2006) Catheter-associated bloodstream infections in pediatric hematology–oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 28:23–28PubMed
7.
Zurück zum Zitat Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR (2011) Higher complication risk of totally implantable venous access port systems in patients with advanced cancer—a single institution retrospective analysis. Palliat Med (in press) Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR (2011) Higher complication risk of totally implantable venous access port systems in patients with advanced cancer—a single institution retrospective analysis. Palliat Med (in press)
8.
Zurück zum Zitat Flynn PM, Willis B, Gaur AH, Shenep JL (2003) Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 21:3520–3525PubMedCrossRef Flynn PM, Willis B, Gaur AH, Shenep JL (2003) Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 21:3520–3525PubMedCrossRef
9.
Zurück zum Zitat Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194PubMedCrossRef Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194PubMedCrossRef
10.
Zurück zum Zitat Donlan RM (2011) Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis 52:1038–1045PubMedCrossRef Donlan RM (2011) Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis 52:1038–1045PubMedCrossRef
11.
Zurück zum Zitat Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedCrossRef Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedCrossRef
12.
Zurück zum Zitat Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J (2009) Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn Microbiol Infect Dis 63:208–212PubMedCrossRef Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J (2009) Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn Microbiol Infect Dis 63:208–212PubMedCrossRef
13.
Zurück zum Zitat Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57:1172–1180PubMedCrossRef Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57:1172–1180PubMedCrossRef
14.
Zurück zum Zitat Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ (1988) Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enter Nutr 12:185–189CrossRef Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ (1988) Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enter Nutr 12:185–189CrossRef
15.
Zurück zum Zitat Guedon C, Nouvellon M, Lalaude O, Lerebours E (2002) Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enter Nutr 26:109–113CrossRef Guedon C, Nouvellon M, Lalaude O, Lerebours E (2002) Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enter Nutr 26:109–113CrossRef
16.
Zurück zum Zitat Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G (2005) Comparative efficacies of quinupristin–dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49:4042–4045PubMedCrossRef Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G (2005) Comparative efficacies of quinupristin–dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49:4042–4045PubMedCrossRef
17.
Zurück zum Zitat Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE (2005) Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 55:792–795PubMedCrossRef Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE (2005) Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 55:792–795PubMedCrossRef
18.
Zurück zum Zitat Lee JY, Ko KS, Peck KR, Oh WS, Song JH (2006) In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57(6):1110–1115PubMedCrossRef Lee JY, Ko KS, Peck KR, Oh WS, Song JH (2006) In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57(6):1110–1115PubMedCrossRef
19.
Zurück zum Zitat Van Praagh AD, Li T, Zhang S, Arya A, Chen L, Zhang XX, Bertolami S, Mortin LI (2011) Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob Agents Chemother 55(9):4081–4089PubMedCrossRef Van Praagh AD, Li T, Zhang S, Arya A, Chen L, Zhang XX, Bertolami S, Mortin LI (2011) Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob Agents Chemother 55(9):4081–4089PubMedCrossRef
20.
Zurück zum Zitat Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55:90–94PubMedCrossRef Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55:90–94PubMedCrossRef
21.
Zurück zum Zitat Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S (2006) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58(4):816–821PubMedCrossRef Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S (2006) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58(4):816–821PubMedCrossRef
22.
Zurück zum Zitat LaPlante KL, Mermel LA (2007) In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22:2239–2246PubMedCrossRef LaPlante KL, Mermel LA (2007) In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22:2239–2246PubMedCrossRef
23.
Zurück zum Zitat Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA (2009) Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58:442–450PubMedCrossRef Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA (2009) Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58:442–450PubMedCrossRef
24.
Zurück zum Zitat Stevens DL (2006) The role of vancomycin in the treatment paradigm. Clin Infect Dis 42(Suppl 1):S51–S57PubMedCrossRef Stevens DL (2006) The role of vancomycin in the treatment paradigm. Clin Infect Dis 42(Suppl 1):S51–S57PubMedCrossRef
25.
Zurück zum Zitat Aumeran C, Thibert E, Chapelle FA, Hennequin C, Lesens O, Traoré O (2012) Assessment on experimental bacterial biofilms and in clinical practice of the efficacy of sampling solutions for microbiological testing of endoscopes. J Clin Microbiol 50:938–942PubMedCrossRef Aumeran C, Thibert E, Chapelle FA, Hennequin C, Lesens O, Traoré O (2012) Assessment on experimental bacterial biofilms and in clinical practice of the efficacy of sampling solutions for microbiological testing of endoscopes. J Clin Microbiol 50:938–942PubMedCrossRef
26.
Zurück zum Zitat Pineau L, Roques C, Luc J, Michel G (1997) Automatic washer disinfector for flexible endoscopes: a new evaluation process. Endoscopy 29:372–379PubMedCrossRef Pineau L, Roques C, Luc J, Michel G (1997) Automatic washer disinfector for flexible endoscopes: a new evaluation process. Endoscopy 29:372–379PubMedCrossRef
27.
Zurück zum Zitat Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47(10):3145–3148PubMedCrossRef Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47(10):3145–3148PubMedCrossRef
28.
Zurück zum Zitat Chauhan A, Lebeaux D, Decante B, Kriegel I, Escande MC, Ghigo JM, Beloin C (2012) A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 7(5):e37281, Epub 2012 May 16PubMedCrossRef Chauhan A, Lebeaux D, Decante B, Kriegel I, Escande MC, Ghigo JM, Beloin C (2012) A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 7(5):e37281, Epub 2012 May 16PubMedCrossRef
29.
Zurück zum Zitat Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C (2009) Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 24:3204–3209PubMedCrossRef Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C (2009) Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 24:3204–3209PubMedCrossRef
30.
Zurück zum Zitat Chaieb K, Zmantar T, Souiden Y, Mahdouani K, Bakhrouf A (2011) XTT assay for evaluating the effect of alcohols, hydrogen peroxide and benzalkonium chloride on biofilm formation of Staphylococcus epidermidis. Microb Pathog 50:1–5PubMedCrossRef Chaieb K, Zmantar T, Souiden Y, Mahdouani K, Bakhrouf A (2011) XTT assay for evaluating the effect of alcohols, hydrogen peroxide and benzalkonium chloride on biofilm formation of Staphylococcus epidermidis. Microb Pathog 50:1–5PubMedCrossRef
31.
Zurück zum Zitat Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CMJE, Schreurs MWJ, Jukema GN (2010) Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat Res 468:2789–2796PubMedCrossRef Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CMJE, Schreurs MWJ, Jukema GN (2010) Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat Res 468:2789–2796PubMedCrossRef
Metadaten
Titel
Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports
verfasst von
C. Aumeran
P. Guyot
M. Boisnoir
C. Robin-Hennequin
M. Vidal
C. Forestier
O. Traore
O. Lesens
Clermont-Ferrand Biofilm Study Group
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 2/2013
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1732-5

Weitere Artikel der Ausgabe 2/2013

European Journal of Clinical Microbiology & Infectious Diseases 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.